Notice on Doing a Good Job in the Fifth Batch of National Organizations of Centralized Procurement and Use of Drugs in this Municipality

All district medical insurance bureaus, health committees, all non-profit medical institutions, medical insurance designated medical institutions, and all relevant pharmaceutical production and operation enterprises:

In order to implement the decision and deployment of the Party Central Committee and the State Council on normalizing the centralized procurement and use of state-organized drugs, in accordance with the "Opinions of the Central Committee of the Communist Party of China and the State Council on Deepening the Reform of the Medical Security System" (Zhongfa [2020] No.
5) and the "Office of the State Council" Opinions of the Office on Promoting the Normalized and Institutionalized Development of Drug Centralized and Volume Procurement Work" (Guobanfa [2021] No.
2) spirit, on June 23, 2021, the National Joint Procurement Office launched the fifth batch of nationally organized drug concentration in Shanghai Procurement work
.

In order to ensure the smooth progress of the centralized procurement and use of drugs organized by the state in this city, and ensure the smooth implementation and orderly transition of the selected results, the fifth batch is now completed on the basis of the implementation of the centralized procurement and use of drugs organized by the state in this city in the early stage.

1.
Prioritize the procurement and use of selected drugs, and encourage non-selected drugs to actively reduce their prices

If the original city-winning drug (or drug listed on the Internet) with the same generic name (including dosage form) as the selected drug is not eligible for selection (hereinafter referred to as "unselected drug"), but the quality and efficacy are guaranteed, and the price is reasonable, medical treatment Institutions can continue to purchase the selected drugs on the premise that they preferentially purchase the selected drugs, and in principle the quantity shall not exceed the selected drugs
.

In the event that the selected products are not supplied in a timely manner, the restrictions on the purchase quantity of the unselected drugs shall be gradually lifted as appropriate

Medical institutions should give full play to the role of clinical pharmacists, strengthen prescription review and prescription reviews of medical institutions, and further strengthen the assessment of rational drug use
.

Strictly implement the requirements for prescriptions under the common name, and give priority to the selected drugs under the same conditions; compared with the selected drugs, they have the same or equivalent active ingredients (especially similar chemical structures), equivalent therapeutic effects (including compound preparations), and clinically feasible Substitution of similar drugs, on the basis of rational use of drugs, should give priority to the use of selected drugs

2.
Adhere to the coordination of medical insurance payment and procurement, and guide the formation of the habit of using medicines

In order to adhere to the coordination mechanism of medical insurance payment and procurement, on the basis of guaranteeing quality and supply, in accordance with the "Shanghai Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2019 Edition)" and the "Regarding the Regulation of Basic Medical Insurance and Work Injury Insurance in Shanghai" "Notice on Issues Concerning the Scope of Drug Payment for Insurance and Maternity Insurance" (Shanghai Medical Insurance Medical Guanfa [2021] No.
8), for the generic name included in the city’s medical insurance drug payment scope but the price is higher than the selected price of the same generic name is not selected drugs (below (Referred to as "high-priced drugs"), in accordance with the principle of "appropriate price", after gradual price reduction or price limit, open the Internet for public negotiation and purchase
.

On this basis, in order to guide patients to form corresponding medication habits, the proportion of personal self-esteem for "highly-priced drugs" is appropriately increased (except for the old Red Army, retired personnel, and revolutionary disabled soldiers from grades one to six)

The generic names of the drugs in the medical insurance catalogue involved in the above-mentioned "high-priced drugs" and the specific self-conceit ratio that individuals need to increase are shown in the appendix of this notice
.

If an insured person uses "high-priced drugs", the medical institution shall mark it in the item details of the medical expense receipt for identification

3.

(1) The procurement of selected drugs, payment for goods, quality supervision and other related issues in the centralized procurement and use of drugs organized by the state shall be implemented in accordance with the relevant provisions of Shanghai Medical Insurance Price Collection [2019] No.

(2) This notice will come into effect on October 20, 2021, and the implementation time of the increase in the self-sufficiency ratio of drugs for urban and rural residents’ basic medical insurance participants who use “highly-priced drugs” will be notified separately by the municipal medical insurance department

Attachment: The fifth batch of national organizations organize centralized drug procurement and use generic names of varieties and increase the self-sufficiency ratio of individuals who use the same varieties of "high-priced drugs"

Shanghai Municipal Medical Security Bureau

Shanghai Municipal Health Commission

Shanghai Drug Administration

September 23, 2021

Attachment: The fifth batch of countries organize centralized procurement of medicines and use generic names of varieties and increase the self-sufficiency ratio of individuals who use the same varieties of "high-priced drugs"

Attachment: The fifth batch of countries organize centralized procurement of medicines and use generic names of varieties and increase the self-sufficiency ratio of individuals who use the same varieties of "high-priced drugs"